Tolerance Induction Using Autologous Regulatory T Cell Infusion and Zortress (Everolimus) in Renal Transplant Recipients: a pilot study

Grants and Contracts Details

StatusFinished
Effective start/end date2/28/17 → 7/31/24

Funding

  • Novartis (domestic): $212,164.00